Amneal Pharmaceuticals, Inc. Class A Common Stock

AMRXNASDAQ • USD
21.38 USD
↘ 0.32 (1.47%)AT CLOSE (03:59 PM EST)
21.37
↘ 0.01 (0.04%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
21.37
↘ 0.01 (0.04%)
🔴Market: CLOSED

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) trades at $21.38 per share. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Key drivers include exceptional Return on Equity (25.1%), a bullish Golden Cross on the moving averages and bullish moving average alignment. AMRX is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$21.49
High?$21.72
Low?$21.30
Prev. Close?$21.70
Volume?1.7M
Avg. Volume?4.0M
VWAP?$21.48
Rel. Volume?0.43x
Bid / Ask
Bid?$21.00 × 600
Ask?$21.74 × 3.6K
Spread?$0.74
Midpoint?$21.37
Valuation & Ratios
Market Cap?7.4B
Shares Out?348.4M
Float?171.0M
Float %?53.5%
P/E Ratio?55.88
P/B Ratio?14.02
EPS?$0.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Employees
8.5K
Market Cap
7.4B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-05-07
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
35
Momentum?
62
Short Sent.?
85
Piotroski F-Score?4/9Mixed
Altman Z-Score?1.98Grey
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.66%Elevated
Short Interest?11.4M
Days to Cover?2.8
Free Float171.0M
Avg Daily Volume4.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.87Adequate
Quick Ratio?1.24Adequate
Cash Ratio?0.14Low
Debt/Equity?6.00High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
56/100
P/E?
Peers
100
S&P
10
55.9PRICEY▾
P/B?
Peers
100
S&P
13
14.02HIGH▾
P/S?
Peers
100
S&P
60
2.33CHEAP▾
P/FCF?
Peers
100
S&P
3
84.5PRICEY▾
EV/EBITDA?
Peers
100
S&P
53
14.5FAIR▾
EV/Sales?
Peers
100
S&P
57
3.28FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
74
25.1%STRONG▾
ROA?
Peers
50
S&P
24
2.5%WEAK▾
Cash Flow & Enterprise
FCF?$88.2M
Enterprise Value?$10.5B
Fundamentals ratios updated end of day